PERSPECTA

News from every angle

← Back to headlines

Vivos Therapeutics Stock Falls on Second Quarter Revenue Miss

Vivos Therapeutics experienced a 6% drop in its stock price after reporting a miss on its second-quarter revenue estimates.

17 Aug, 10:24 — 17 Aug, 10:24
PostShare

Sources

Showing 1 of 1 sources
investing-com10h ago

Vivos Therapeutics stock falls 6% on second quarter revenue miss By Investing.com - Investing.com South Africa

Vivos Therapeutics stock falls 6% on second quarter revenue miss By Investing.com  Investing.com South Africa

Read full article →

Related Stories

Bulgaria Returns 11.6 Tons of Peppers to North Macedonia Due to Pesticides

39m ago

Goldman Sachs to Acquire ETF Provider Neos in $2.3 Billion Deal

45m ago

L3Harris CEO Chris Kubasik Ousted Over Unspecified Conduct

47m ago

KBR Secures $60 Million NATO Contract for Missile Defense System

57m ago